Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 13/02/2026

    Molekulare Ursache von Strahlenschäden identifiziert

    A severe side effect of radiation therapy can be debilitating fibrotic skin damage. Scientists at the German Cancer Research Center (DKFZ) have now identified a key factor in the development of this radiation damage. Modulating this factor could potentially prevent this severe adverse effect.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/molekulare-ursache-von-strahlenschaeden-identifiziert
  • Press release - 04/02/2026

    A double-edged sword: Chronic cellular stress promotes liver cancer - but at the same time renders tumors vulnerable to immunotherapy

    A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response to the tumor. This has now been published in the journal Nature by a team led by researchers from the DKFZ, the UKT, and the Sanford Burnham Prebys Medical Discovery Institute. However, the results also show that this very mechanism could help identify patients who respond particularly well to immunotherapy in the…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/double-edged-sword-chronic-cellular-stress-promotes-liver-cancer-same-time-renders-tumors-vulnerable-immunotherapy
  • Rewriting the transcript to heal diseases - 29/01/2026 A colourful mRNA to which an arginyl tRNA docks. Both nucleic acid sequences are modified at one point.

    Therapy involving the umlauts of the genetic alphabet

    tRNAs are essential components of the protein synthesis machinery that also act as molecular switches in gene regulation and consequently in disease processes such as cancer. The Heidelberg-based start-up Umlaut.bio is developing novel therapeutics that specifically target tRNAs to intervene at the molecular origin of disease.

    https://www.gesundheitsindustrie-bw.de/en/article/news/therapy-involving-umlauts-genetic-alphabet
  • Press release - 22/01/2026

    NAKO study confirms link between smoking and depression

    A research group led by the Central Institute of Mental Health in Mannheim has confirmed for the first time within the German National Cohort an association between cigarette consumption and depression. The findings show that depression occurs more frequently over the lifetime of current and former smokers than among those who have never smoked.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nako-study-confirms-link-between-smoking-and-depression
  • Press release - 20/01/2026

    Exciva raises €51 million ($59m) in Series B funding round co-led by Gimv and EQT

    Exciva GmbH, a biopharmaceutical company developing novel therapeutic compounds for the treatment of neuropsychiatric conditions, today announces the closing of a €51 million ($59m) Series B financing round. Gimv and EQT Life Sciences co-led the round. Additional participants included new investors Fountain Healthcare Partners, LifeArc Ventures, Carma Fund and Modi Ventures, as well as existing investors Andera Partners and LBBW.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/exciva-raises-euro-51-million-dollar-59m-series-b-funding-round-co-led-gimv-and-eqt
  • Press release - 08/01/2026

    Award for EMG electrode research

    How modern medical technology can prevent serious consequences of surgical procedures is demonstrated by a recent internationally recognized scientific publication. The study “Validation of conductive resin as electrode material in neuromonitoring with 3D-printed probes” under the leadership of Drs. Kiese and Bucher was awarded at the ICST Conference in Japan and highlights a medical topic that is crucial for the quality of life of many people.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-emg-electrode-research
  • Press release - 22/12/2025

    Slow down to get ahead

    To ensure that protein production in our cells runs smoothly, the protein complex NAC slows down the rate of protein synthesis right at the start. An international research team with significant involvement of Konstanz biologists has now discovered what underlies this previously unknown function of NAC.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/slow-down-get-ahead
  • Press release - 16/12/2025

    New measures to make EU health sector more innovative, competitive and resilient

    The European Commission has today proposed an ambitious package of measures to improve the health of EU citizens, while ensuring the long-term resilience and competitiveness of the health sector.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-measures-make-eu-health-sector-more-innovative-competitive-and-resilient
  • Press release - 25/11/2025

    CELLnROLL receives funding from EXIST Research Transfer

    CELLnROLL is a spin-off from the Max Planck Institute for Intelligent Systems. The newly founded company develops a high-precision microrobotic-based cell sorting system to help clinicians make fast, affordable, and informed decisions for cancer diagnostics. Now, the project has received €865,000 in funding through the EXIST Transfer of Research program, a funding program initiated by the German Federal Ministry for Economic Affairs and Energy.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cellnroll-receives-funding-exist-research-transfer
  • Press release - 21/11/2025

    DFG approves two Collaborative Research Centres

    In the current selection round, the German Research Foundation (DFG) has granted funding for two new Collaborative Research Centres at the University of Konstanz. Over the next four years, the research teams will be working intensively on trigger signals in biological cells as well as on "silence" and "noise" in human speech.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dfg-approves-two-collaborative-research-centres
  • Dossier - 20/11/2025 A stethoscope and blood pressure monitor

    Prevention as the key to health

    Many serious illnesses can be prevented or at least mitigated through healthy lifestyles and early diagnosis. However, effective prevention requires holistic approaches at all levels of healthcare and the reinforcement of individual health literacy.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/prevention-key-health
  • Press release - 18/11/2025

    Careers in conversation: connecting academia and industry

    Sixteen leading life science and IT companies, all-new livestreamed presentations, and an informative career panel made for a successful EMBL Industry Day in its second year

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/careers-conversation-connecting-academia-and-industry
  • Press release - 17/11/2025

    How painkillers can contribute to anemia in cancer patients

    Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer patients.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-painkillers-can-contribute-anemia-cancer-patients
  • Press release - 13/11/2025

    Collaboration between KyooBe Tech and the German Center for Infection Research

    The technology company KyooBe Tech GmbH and the German Center for Infection Research (DZIF) have signed a memorandum of understanding to collaborate on future research and development projects. The aim of the collaboration is to evaluate an innovative technology for inactivating pathogens using the specific effect of low-energy accelerated electrons (Low Energy Electron Irradiation—LEEI) and to make it available to DZIF scientists.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/collaboration-between-kyoobe-tech-and-german-center-infection-research
  • Press release - 13/11/2025

    Agile, lightweight, efficient, intelligent: Researchers are developing next-generation robots

    At the new Institute for Adaptive Mechanical Systems (IAMS) at the University of Stuttgart, the focus is on a new generation of walking robots and “soft robotics”. The researchers are developing adaptable robots inspired by natural movement patterns and made from innovative soft materials. The applications range from healthcare and industrial production to energy supply.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/agile-lightweight-efficient-intelligent-researchers-are-developing-next-generation-robots
  • Artificial intelligence: opportunities for healthcare - 06/11/2025 Graphic showing various options for integrating GenAI into a company. These are via SiaS tokens, in a private cloud and with proprietary hardware. They are compared in terms of initial costs, running costs, data security and dependency.

    More than just deskwork: opportunities and obstacles for generative AI in healthcare

    Generative artificial intelligence (GenAI) has enormous potential in healthcare, ranging from automating time-consuming deskwork to supporting diagnoses. It is not just for the big players; there are also cost-effective ways for smaller companies and institutions to utilize GenAI.

    https://www.gesundheitsindustrie-bw.de/en/article/news/more-just-deskwork-opportunities-and-obstacles-generative-ai-healthcare
  • Press release - 05/11/2025

    LICIT Solution raises Series A to accelerate sustainable antimicrobial innovation

    LICIT Solutions completes Series A financing to accelerate the development and commercialization of next-generation sustainable active ingredients for hygiene, preservation, and protective applications LICIT Solutions GmbH, a spin-out from the Institute for Clinical Anatomy and Cell Analysis at the University of Tübingen, has successfully completed its Series A financing round.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/licit-solution-raises-series-accelerate-sustainable-antimicrobial-innovation
  • Press release - 28/10/2025

    AI solutions from the DKFZ set new standards in medical image processing

    Researchers at the German Cancer Research Center (DKFZ) have achieved outstanding success at this year's world-leading forum for medical image processing and computer-assisted intervention. Two DKFZ departments competed in eight international AI competitions – and won seven of them. The successes cover key areas of oncology – from early detection and diagnosis to therapy support and follow-up care.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ai-solutions-dkfz-set-new-standards-medical-image-processing
  • Press release - 10/10/2025

    Acidic tumor environment promotes survival and growth of cancer cells

    Tumors are not a comfortable place to live: oxygen deficiency, nutrient scarcity, and the accumulation of sometimes harmful metabolic products constantly stress cancer cells. A research team from the DKFZ and the IMP in Vienna has now discovered that the acidic pH value in tumor tissue is a decisive factor in how pancreatic cancer cells adapt their energy metabolism in order to survive under these adverse conditions.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/acidic-tumor-environment-promotes-survival-and-growth-cancer-cells
  • Using nanostructures to fight bacteria - 09/10/2025 Four images showing that bacteria adhere much less readily to the nanoshape surface: in the top row, two blue-stained microscopic images – on the left, an untreated surface with a large number of colonies; on the right, nanoshape with far fewer colonies. Below are two images showing a schematic representation of the principle: bacteria on a smooth surface and on an implant with serrations.

    Inspired by insect wings: antibacterial surfaces for implants

    What do dragonfly wings and dental implants have in common? Nothing yet but that could soon change. The Karlsruhe-based start-up nanoshape has developed a process for coating medical implants with nanostructures similar to those found on insect wings. The coating makes surfaces bacteria-repellent and is aimed at reducing the risk of post-surgical inflammation. The first product could be on the market as early as next year.

    https://www.gesundheitsindustrie-bw.de/en/article/news/Inspired-by-insect-wings-antibacterial-surfaces-for-implants
  • Press release - 23/09/2025

    Mutation in non-coding DNA worsens leukaemia prognosis Ulm study uncovers previously unknown disease-promoting mechanism

    Why is blood cancer particularly aggressive in some patients? Researchers at Ulm University Hospital have characterised a mutation in the so-called NOTCH1 gene that significantly influences the prognosis of chronic lymphocytic leukaemia (CLL). Remarkably, this mutation is located in the non-coding region of the gene – an area of DNA long considered less relevant for disease mechanisms.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/mutation-non-coding-dna-worsens-leukaemia-prognosis-ulm-study-uncovers-previously-unknown-disease-promoting-mechanism
  • Press release - 18/09/2025

    groninger acquires Reinraumtechnik Ulm

    The groninger Group has acquired Reinraumtechnik Ulm GmbH (RTU). With this strategic move, the family-owned company headquartered in Crailsheim not only expands its technological portfolio but also strengthens its expertise in a field that is crucial to the pharmaceutical industry: cleanroom and isolator technology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/groninger-acquires-reinraumtechnik-ulm
  • Press release - 09/09/2025

    Soft materials for smarter robots

    Soft robots, robot systems made of soft materials, open up new perspectives for medical technology and industry. Jun.-Prof. Dr. Aniket Pal from the University of Stuttgart is conducting research into viscoelastic materials that have the potential to embed intelligent functions in soft robots. He is receiving 1.5 million euros in funding for this research as part of the Emmy Noether Program. The funding period began on September 1, 2025.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/soft-materials-smarter-robots
  • Press release - 03/09/2025

    Nature publication: Mechanical tensions as a driver of evolution

    When embryos grow, cells and tissue are constantly bumping into each other. This creates mechanical tensions that could endanger their development. A team from University of Hohenheim and the Japanese RIKEN Center have discovered that fly embryos have strategies to deal with this pressure. The different species have developed two different solutions. This ability to control mechanical tension could be a key to why so many body plans have evolved.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nature-publication-mechanical-tensions-driver-evolution
  • Press release - 29/08/2025

    Sleeping beauties: the biology behind oocyte dormancy

    The maturation process of oocytes remains paused for several years. Researchers from Konstanz and Göttingen have now found out which protein ensures this state is maintained over such a long period.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/sleeping-beauties-biology-behind-oocyte-dormancy

Page 1 / 10

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2026
Website address: https://www.gesundheitsindustrie-bw.de/en/search